参考文献/References:
[1]陈燕华,房梦雅,耿劲松,等.中国大陆高血压健康素养研究的文献计量分析[J].医学信息,2020,33(9):1-5,8.[2]Band R,Bradbury K.Intervention planning for a digital intervention for self-management of hypertension:a theoryevidenceand person-based approach[J].Implementation Science,2017,12(1):25. [3]蔡利,单岩,杜理平,等.国外行为改变轮理论的概述与实践[J].解放军护理杂志,2019,36(7):59-62. [4]王家威,樊琼玲,罗园园,等.哈萨克族牧民新发高血压影响因素的Cox比例风险模型分析[J].中国全科医学,2019,22(30):3672-3678.[5]Michie S,van Stralen MM,West R.The behaviour change wheel:a new method for characterising and designing behaviour change interventions[J].Implementation Science,2011(6):42.[6]曾望远,周素云,顾申红.海口市社区高血压现状调查及全科干预效果研究[J].中国全科医学,2020,23(18):2335-2341. [7]刘宁,张婧珺,鱼星锋,等.高血压病人自我管理量表的研制与信效度检验[J].护理研究,2015,(14):1764-1767.[8]蔡敏章,马明辉,刘来新,等.社区不同高血压管理模式对患者血压控制的影响[J].中国卫生政策研究,2017,10(12):49-53. [9]井丽,田园梦,林敏,等.辽宁省农村地区出血性卒中患病情况及影响因素分析[J].中国慢性病预防与控制,2019,27(12):917-921. [10]王家威,樊琼玲,张雪莲,等.终止高血压膳食疗法(DASH)对乌鲁木齐南山牧区牧民高血压前期的干预研究[J].新疆医科大学学报,2020,43(7):962-966,975.
相似文献/References:
[1]颜 明,龚丽娜,王淑清.彩超在高血压患者肾动脉血流动力学检测中的应用分析[J].医学信息,2018,31(02):156.[doi:10.3969/j.issn.1006-1959.2018.02.060]
YAN Ming,GONG Li-na,WANG Shu-qing.Application of Color Doppler Ultrasound in the Measurement of Renal Artery Hemodynamics in Patients with Hypertension[J].Medical Information,2018,31(18):156.[doi:10.3969/j.issn.1006-1959.2018.02.060]
[2]夏能能,任 薇,杜建平,等.1953~2016年中医药治疗高血压领域研究热点分析[J].医学信息,2018,31(04):18.[doi:10.3969/j.issn.1006-1959.2018.04.007]
XIA Neng-neng,REN Wei,DU Jian-ping,et al.Analysis of Hot Spots in the Research of Traditional Chinese Medicine in Treating Hypertension from 1953 to 2016[J].Medical Information,2018,31(18):18.[doi:10.3969/j.issn.1006-1959.2018.04.007]
[3]靳雪芹,邓正聪.代谢综合征与肿瘤关系的研究进展[J].医学信息,2018,31(05):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
JIN Xue-qin,DENG Zheng-cong.Research Progress on the Relationship between Metabolic Syndrome and Tumor[J].Medical Information,2018,31(18):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
[4]乔 君,高 翔,王 瑜,等.缬沙坦对原发性高血压患者外周PBMC中IL-17表达的影响[J].医学信息,2018,31(07):65.[doi:10.3969/j.issn.1006-1959.2018.07.021]
QIAO Jun,GAO Xiang,WANG Yu,et al.The Effect of Valsartan on the Expression of IL-17 in Peripheral PBMC of Patients with Essential Hypertension[J].Medical Information,2018,31(18):65.[doi:10.3969/j.issn.1006-1959.2018.07.021]
[5]董巧玲.健康教育对原发性高血压患者治疗效果的影响[J].医学信息,2018,31(09):180.[doi:10.3969/j.issn.1006-1959.2018.09.060]
DONG Qiao-ling.Effect of Health Education on Treatment of Patients with Essential Hypertension[J].Medical Information,2018,31(18):180.[doi:10.3969/j.issn.1006-1959.2018.09.060]
[6]沈 正,王庆海.焦虑抑郁障碍与血压变异性研究[J].医学信息,2018,31(16):34.[doi:10.3969/j.issn.1006-1959.2018.16.010]
SHEN Zheng,WANG Qing-hai.Study on Anxiety and Depression Disorder and Blood Pressure Variability[J].Medical Information,2018,31(18):34.[doi:10.3969/j.issn.1006-1959.2018.16.010]
[7]左洪亮.苯磺酸左旋氨氯地平片治疗中老年患者
轻中度原发性高血压的疗效观察[J].医学信息,2018,31(16):120.[doi:10.3969/j.issn.1006-1959.2018.16.037]
ZUO Hong-liang.Efficacy of Levamlodipine Besylate Tablets in Treatment of Mild to Moderate Essential Hypertension in Middle-aged and Elderly Patients[J].Medical Information,2018,31(18):120.[doi:10.3969/j.issn.1006-1959.2018.16.037]
[8]袁 敏,周袁成.钙离子拮抗剂类降压药的临床应用与不良反应分析[J].医学信息,2018,31(17):125.[doi:10.3969/j.issn.1006-1959.2018.17.038]
YUAN Min,ZHOU Yuan-cheng.Clinical Application and Adverse Reaction Analysis of Calcium Antagonist Antihypertensive Drugs[J].Medical Information,2018,31(18):125.[doi:10.3969/j.issn.1006-1959.2018.17.038]
[9]陈学军,李 敏,张 丹,等.社区一体化分级管理模式对社区老年高血压患者的管理效果[J].医学信息,2018,31(18):169.[doi:10.3969/j.issn.1006-1959.2018.18.055]
CHEN Xue-jun,LI Min,ZHANG Dan,et al.Management Effect of Community Integration Hierarchical Management Mode on Elderly Hypertensive Patients in Community[J].Medical Information,2018,31(18):169.[doi:10.3969/j.issn.1006-1959.2018.18.055]
[10]张莉莉.左旋氨氯地平和氨氯地平治疗轻中度高血压临床效果观察[J].医学信息,2018,31(21):149.[doi:10.3969/j.issn.1006-1959.2018.21.043]
ZHANG Li-li.Clinical Efficacy of Levamlodipine and Amlodipine in Treatment of Mild to Moderate Hypertension[J].Medical Information,2018,31(18):149.[doi:10.3969/j.issn.1006-1959.2018.21.043]